Zacks Investment Research lowered shares of Abcam (OTCMKTS:ABCZY) from a buy rating to a hold rating in a report issued on Friday.

According to Zacks, “Abcam PLC distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam PLC is headquartered in Cambridge, the United Kingdom. “

Shares of Abcam (OTCMKTS ABCZY) opened at $15.91 on Friday. Abcam has a one year low of $9.60 and a one year high of $16.08.

COPYRIGHT VIOLATION WARNING: This story was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another site, it was stolen and reposted in violation of US & international copyright legislation. The original version of this story can be read at https://www.dailypolitical.com/2018/01/15/abcam-abczy-cut-to-hold-at-zacks-investment-research.html.

Get a free copy of the Zacks research report on Abcam (ABCZY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.